Hap Trading, LLC Atara Biotherapeutics, Inc. Transaction History
Hap Trading, LLC
- $1.06 Trillion
- Q2 2025
A detailed history of Hap Trading, LLC transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 10,100 shares of ATRA stock, worth $126,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,100Holding current value
$126,856% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ATRA
# of Institutions
5Shares Held
2.89MCall Options Held
0Put Options Held
0-
Kpcb Xv Associates, LLC1.88MShares$23.6 Million19.79% of portfolio
-
Antipodean Advisors LLC New York, NY1MShares$12.6 Million8.12% of portfolio
-
American Portfolios Advisors Holbrook, NY4.5KShares$56,5200.0% of portfolio
-
Wipfli Financial Advisors Llc,3.08KShares$38,6720.0% of portfolio
-
Act Capital Management, LLC Wayne, PA900Shares$11,3040.0% of portfolio
About Atara Biotherapeutics, Inc.
- Ticker ATRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,362,304
- Market Cap $1.19B
- Description
- Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...